In this case PA Group is the pharmaceutical industry that include to Industries where few companies capitalize internally generated development costs and most companies charge them to income as incurred. As an internally generated intangible asset, development costs are required to satisfy additional criteria set out by IAS 38 apart from the definition and recognition:
Development Cost can be capitalized and recognized as an intangible asset if it
satisfies the conditions of technical feasibility, intention to complete the project, availability of adequate resources for the project, demonstrate the existence of market for the output to be generated by this intangible asset.
PA group included a $5 million expenditure in the inventory. this $5 million was
previously written off in the income statement. PA Group should therefore reverse the capitalisation